The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 5, 2013, Pages 544-551

  Rittman, Timothy ^a   Ghosh, Boyd C ^a   McColgan, Peter ^a   Breen, David P ^a   Evans, Jonathan ^a   Williams Gray, Caroline H ^a   Barker, Roger A ^a   Rowe, James B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

AGED; ARTICLE; ATTENTION; CONTROLLED STUDY; DEPTH PERCEPTION; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FALSE POSITIVE RESULT; FEMALE; HUMAN; IDIOPATHIC DISEASE; LANGUAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL CONCENTRATION; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PARKINSONISM; PATIENT ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RECEIVER OPERATING CHARACTERISTIC; REVISED ADDENBROOKE COGNITIVE EXAMINATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VERBAL BEHAVIOR;

EID: 84876130619     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-303618     Document Type: Article

References (40)

1. Shaw LM, Korecka M, Clark CM, et al. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nat Rev Drug Discov 2007;6:295-303. (Pubitemid 46505880)
2. Zheng Y, Cai T, Feng Z. Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers. Biometrics 2006;62:279-87.
3. Williams-Gray C, Foltynie T, Brayne C, et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-98. (Pubitemid 47343805)
4. Ghosh BCP, Rowe JB, Calder AJ, et al. Emotion recognition in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2009;80:1143-5.
5. Millar D, Griffiths P, Zermansky AJ, et al. Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy. Mov Disord 2006;21:199-207.
6. Kertesz A, McMonagle P. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy. J Neurol Sci 2010;289:138-43.
7. Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 1998;55:957-61. (Pubitemid 28335114)
8. Mathew R, Bak TH, Hodges JR. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 2011;83:405-10.
9. Aarsland D, Litvan I, Salmon D. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:1215-21.
10. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease. Neurology 1995;45:1477-83.
11. Bak TH, Rogers TT, Crawford LM, et al. Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2005;76:420-2. (Pubitemid 40299137)
12. Brenneis C, Seppi K, Schocke M, et al. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004;75:246-9. (Pubitemid 38183532)
13. Price S, Paviour DC, Scahill R, et al. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 2004;23:663-9. (Pubitemid 39370617)
14. Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008;29:280-9.
15. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006;63:81-6. (Pubitemid 43063865)
16. Mioshi E, Dawson K, Mitchell J, et al. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006;21:1078-85. (Pubitemid 44762726)
17. Alexopoulos P, Ebert A, Richter-Schmidinger T, et al. Validation of the German revised Addenbrooke's Cognitive Examination for detecting mild cognitive impairment, mild dementia in Alzheimer's disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2010;29:448-56.
18. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9. (Pubitemid 26243849)
19. Robin X, Turck N, Hainard A, et al. PROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
20. Prince M, Bryce R, Ferri C, et al. World Alzheimer Report 2011: The Benefits of Early Diagnosis and Intervention. London: Alzheimer's Disease International, 2011.
21. García-Caballero A, García-Lado I, González-Hermida J, et al. Validation of the Spanish version of the Addenbrooke's Cognitive Examination in a rural community in Spain. Int J Geriatr Psychiatry 2006;21:239-45.
22. Yoshida H, Terada S, Honda H, et al. Validation of Addenbrooke's Cognitive Examination for detecting early dementia in a Japanese population. Psychiatry Res 2011;185:211-14.
23. Henry JD, Crawford JR. Verbal fluency deficits in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc 2004;10:608-22. (Pubitemid 39077201)
24. Rosser A, Hodges JR. Initial letter and semantic category fluency in Alzheimer's disease, Huntington's disease, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1994;57:1389-94. (Pubitemid 24342306)
25. Graham NL, Bak TH, Patterson K, et al. Language function and dysfunction in corticobasal degeneration. Neurology 2003;61:493-9. (Pubitemid 37025366)
26. Shedlack KJ, Hunter R, Wyper D, et al. The pattern of cerebral activity underlying verbal fluency shown by split-dose single photon emission tomography (SPET or SPECT) in normal volunteers. Psychol Med 1991;21:687-96.
27. Heim S, Eickhoff SB, Amunts K. Different roles of cytoarchitectonic BA 44 and BA 45 in phonological and semantic verbal fluency as revealed by dynamic causal modelling. Neuroimage 2009;48:616-24.
28. Stuss DT, Alexander MP, Hamer L, et al. The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc 1998;4:265-78. (Pubitemid 28339748)
29. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-46. (Pubitemid 35278715)
30. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007;17:74-82.
31. Braak H, Tredici KD, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
32. Shiner T, Seymour B, Wunderlich K, et al. Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease. Brain 2012;135:1871-83.
33. Bak TH, Caine D, Hearn VC, et al. Visuospatial functions in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2006;77:454-6.
34. Clark CM, Sheppard L, Fillenbaum GG, et al. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease. Ann Neurol 1999;56:857-62.
35. McColgan P, Evans J. Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease. Mov Disord 2012;27:1164-79.
36. Bensimon G, Ludolph A, Agid Y, et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009;132:156-71.
37. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128:1247-58. (Pubitemid 40826179)
38. Evidente VGH, Adler CH, Sabbagh MN, et al. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP? Parkinsonism Relat Disord 2011;17:365-71.
39. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006;66:41-8. (Pubitemid 43739589)
40. Ling H, O'Sullivan SS, Holton JL, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 2010;133:2045-57.